Gardasil 9 vaccine could curb cervical cancers and health costs if adopted widely: Yale

A Yale-led study finds that a new vaccine for human papillomavirus (HPV) would significantly reduce both cervical cancer incidence and healthcare costs if states coordinated policies to improve coverage. The study was published April 18 by Proceedings of the National Academy of Sciences. HPV, the most common sexually transmitted infection in the United States, is the ["]